Filing Details
- Accession Number:
- 0001140361-16-089118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-08 16:53:49
- Reporting Period:
- 2016-12-06
- Filing Date:
- 2016-12-08
- Accepted Time:
- 2016-12-08 16:53:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033409 | N Fredric Eshelman | 8 Sylvan Way Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-06 | 337,680 | $34.15 | 641,106 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-12-07 | 172,764 | $33.61 | 813,870 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-12-07 | 86,587 | $32.90 | 900,457 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-12-08 | 19,188 | $32.51 | 919,645 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-12-08 | 5,501 | $33.19 | 925,146 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 944,537 | Indirect | See footnote |
Footnotes
- Represents the weighted average purchase price of the shares purchased ranging from a low of $33.83 to a high of $34.80 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for these transactions and the other transactions reported on this Form 4 and described in notes 2 through 5.
- Represents the weighted average purchase price of the shares purchased ranging from a low of $33.29 to a high of $34.27 per share.
- Represents the weighted average purchase price of the shares purchased ranging from a low of $32.29 to a high of $33.28 per share.
- Represents the weighted average purchase price of the shares purchased ranging from a low of $32.07 to a high of $33.06 per share.
- Represents the weighted average purchase price of the shares purchased ranging from a low of $33.07 to a high of $33.25 per share.
- These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.
Billionaire Hedge Funds
